X

Trial Profile

An Extension Study to Investigate the Safety and Durability of Clinical Activity of GS-1101 in Patients with Hematologic Malignancies [EXTENSION OF 700059751]

Status: Active, no longer recruiting

Phase of Trial: Clinical Phase Unknown

Latest Information Update: 16 Apr 2015

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Idelalisib (Primary)
Indications Chronic lymphocytic leukaemia
Focus Adverse reactions
Sponsors Gilead Sciences

Most Recent Events

11 Jul 2013 M.D. Anderson record 2011-0612 has an incorrect NCT ID (NCT01090414), which matches 2011-1182. They say it should be NCT01659021 and they will correct it (but that also appears to be incorrect)..
11 Jul 2013 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com